The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AMICUS THERAPEUTICS INC | COM | 03152W109 | BBG000PLF6N0 | 14,830,866 | 1,495,047 | SH | SOLE | 1,284,704 | 0 | 210,343 | ||
| APPLIED THERAPEUTICS INC | COM | 03828A101 | BBG000DD0489 | 10,326,864 | 2,211,320 | SH | SOLE | 1,799,351 | 0 | 411,969 | ||
| ARCELLX INC | COMMON STOCK | 03940C100 | BBG00QHJM4S9 | 15,492,330 | 280,709 | SH | SOLE | 280,709 | 0 | 0 | ||
| ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | BBG00QN8K4M4 | 350,000 | 5,000,000 | SH | Call | SOLE | 5,000,000 | 0 | 0 | |
| ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | BBG00QN8K4M4 | 8,978,146 | 965,392 | SH | SOLE | 965,392 | 0 | 0 | ||
| AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | BBG00KVT05R6 | 9,266,307 | 2,662,732 | SH | SOLE | 2,019,233 | 0 | 643,499 | ||
| BIOHAVEN LTD | COM | G1110E107 | BBG017BXV3Q9 | 8,096,281 | 233,255 | SH | SOLE | 209,851 | 0 | 23,404 | ||
| BLACK DIAMOND THERAPEUTICS I | COM | 09203E105 | BBG00MS4Y0W9 | 3,141,763 | 674,198 | SH | SOLE | 516,865 | 0 | 157,333 | ||
| CABALETTA BIO INC | COM | 12674W109 | BBG00MJ3BKW2 | 8,812,225 | 1,178,105 | SH | SOLE | 946,677 | 0 | 231,428 | ||
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | BBG000FW8LZ9 | 5,346,724 | 144,467 | SH | SOLE | 144,467 | 0 | 0 | ||
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | 21833P301 | BBG0078PJKQ7 | 4,591,925 | 101,479 | SH | SOLE | 82,355 | 0 | 19,124 | ||
| CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | BBG00BC59224 | 24,683,545 | 551,095 | SH | SOLE | 478,533 | 0 | 72,562 | ||
| DENALI THERAPEUTICS INC | COM | 24823R105 | BBG008P7F869 | 5,828,452 | 251,010 | SH | SOLE | 251,010 | 0 | 0 | ||
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | BBG00K4Y2H24 | 4,881,737 | 271,057 | SH | SOLE | 271,057 | 0 | 0 | ||
| FULCRUM THERAPEUTICS INC | COM | 359616109 | BBG00DDY1RK9 | 4,318,077 | 696,464 | SH | SOLE | 696,464 | 0 | 0 | ||
| GSK PLC | SPONSORED ADR | 37733W204 | BBG000BLB481 | 9,468,421 | 245,933 | SH | SOLE | 245,933 | 0 | 0 | ||
| HELIX ACQUISITION CORP II | CL A ORD SHS | G4444H101 | BBG01L3GYF02 | 2,044,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| IDEAYA BIOSCIENCES INC | COM | 45166A102 | BBG00CTZ4D83 | 3,573,742 | 101,787 | SH | SOLE | 101,787 | 0 | 0 | ||
| IMMATICS N.V | SHS | N44445109 | BBG00VTL2H76 | 5,835,645 | 502,207 | SH | SOLE | 502,207 | 0 | 0 | ||
| IMMUNOCORE HLDGS PLC | ADS | 45258D105 | BBG00YYCXFB9 | 11,500,605 | 339,351 | SH | SOLE | 241,205 | 0 | 98,146 | ||
| IMMUNOVANT INC | COM | 45258J102 | BBG00P5MC0Q8 | 26,713,606 | 1,011,879 | SH | SOLE | 805,446 | 0 | 206,433 | ||
| INSMED INC | COM PAR $.01 | 457669307 | BBG000BWM5P3 | 5,827,660 | 86,980 | SH | SOLE | 86,980 | 0 | 0 | ||
| JANUX THERAPEUTICS INC | COM | 47103J105 | BBG00ZHSKH11 | 3,893,634 | 92,949 | SH | SOLE | 78,159 | 0 | 14,790 | ||
| JASPER THERAPEUTICS INC | COM NEW | 471871202 | BBG00QPZNP97 | 3,263,693 | 143,775 | SH | SOLE | 122,270 | 0 | 21,505 | ||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | BBG0026ZG5B0 | 8,679,092 | 736,765 | SH | SOLE | 622,215 | 0 | 114,550 | ||
| LARIMAR THERAPEUTICS INC | COM | 517125100 | BBG001J2NVH0 | 5,106,530 | 704,349 | SH | SOLE | 616,726 | 0 | 87,623 | ||
| MERCK & CO INC | COM | 58933Y105 | BBG000BPD168 | 10,153,452 | 81,508 | SH | SOLE | 81,508 | 0 | 0 | ||
| MERUS N V | COM | N5749R100 | BBG00B8LXMS5 | 17,080,486 | 288,668 | SH | SOLE | 288,668 | 0 | 0 | ||
| NEUROGENE INC | COM | 64135M105 | BBG005Y0QDK1 | 2,860,290 | 78,601 | SH | SOLE | 78,601 | 0 | 0 | ||
| NURIX THERAPEUTICS INC | COM | 67080M103 | BBG00SDJ8M78 | 4,242,308 | 203,273 | SH | SOLE | 203,273 | 0 | 0 | ||
| PERCEPTIVE CAP SOLUTIONS COR | CL A ORD SHS | G70077105 | BBG01N0FG6L0 | 1,509,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| PERSPECTIVE THERAPEUTICS INC | COM NEW | 46489V302 | BBG000BG5HT7 | 3,427,786 | 343,810 | SH | SOLE | 343,810 | 0 | 0 | ||
| PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | BBG00W9LF2G5 | 1,210,152 | 29,259 | SH | SOLE | 29,259 | 0 | 0 | ||
| PROTARA THERAPEUTICS INC | COM STK | 74365U107 | BBG001ZLYSH5 | 2,046,955 | 984,113 | SH | SOLE | 984,113 | 0 | 0 | ||
| PYXIS ONCOLOGY INC | COMMON STOCK | 747324101 | BBG00PQFFCV5 | 3,980,854 | 1,202,675 | SH | SOLE | 1,026,159 | 0 | 176,516 | ||
| ROIVANT SCIENCES LTD | SHS | G76279101 | BBG007STW2B8 | 28,673,672 | 2,712,741 | SH | SOLE | 2,712,741 | 0 | 0 | ||
| SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | BBG00WVTHPN2 | 2,372,454 | 124,866 | SH | SOLE | 124,866 | 0 | 0 | ||
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | BBG0067L94B2 | 3,537,080 | 150,450 | SH | SOLE | 71,181 | 0 | 79,269 | ||
| SURROZEN INC | COM NEW | 86889P208 | BBG00XY94S95 | 1,571,435 | 143,510 | SH | SOLE | 116,103 | 0 | 27,407 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | BBG000R33JY1 | 28,991,973 | 1,412,176 | SH | SOLE | 1,213,080 | 0 | 199,096 | ||
| TSCAN THERAPEUTICS INC | COM | 89854M101 | BBG00PH1N007 | 4,943,654 | 845,069 | SH | SOLE | 702,167 | 0 | 142,902 | ||
| VIGIL NEUROSCIENCE INC | COM | 92673K108 | BBG00YGBK4Q4 | 2,977,648 | 744,412 | SH | SOLE | 579,340 | 0 | 165,072 | ||
| VISTAGEN THERAPEUTICS INC | COM | 92840H400 | BBG000BB33L9 | 1,561,385 | 616,749 | SH | SOLE | 616,749 | 0 | 0 | ||
| VISTAGEN THERAPEUTICS INC | COM | 92840H400 | BBG000BB33L9 | 4,286,779 | 1,231,833 | SH | SOLE | 1,231,833 | 0 | 0 | ||